Effect of Blood Transfusions on the Outcome of Very Low Body Weight Preterm Infants under Two Different Transfusion Criteria  by Chen, Hsiu-Lin et al.
©2009 Taiwan Pediatric Association
ORIGINAL ARTICLE
Pediatr Neonatol 2009;50(3):110−116
*Corresponding author. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 
No. 100, Tzyou 1st Road, San Ming District, Kaohsiung 807, Taiwan.
E-mail: 840062@ms.kmuh.org.tw
This study was supported by a grant from the Premature Baby Foundation of Taiwan (Grant no. 9501).
Background: Multiple packed red blood cell (PRBC) transfusions in very low birth 
weight (VLBW) prematurity have been suggested to be a risk factor for the devel-
opment of retinopathy of prematurity (ROP) or for chronic lung disease (CLD). The 
purpose of this study was to examine the effect of PRBC transfusions on the outcome 
of VLBW prematurity.
Methods: In total, between July 2005 and June 2006, 36 VLBW preterm babies 
were admitted to our neonatal intensive care unit and were randomly allocated to 
the “restrictive” (n = 19) or “liberal” (n = 17) criteria for PRBC transfusion. Complete 
blood count (CBC) was examined at admission and 30 days later. Reticulocyte counts, 
serum iron and ferritin were examined and compared with the clinical outcomes.
Results: Infants in the liberal group received a larger PRBC transfusion volume 
compared with the restrictive group over 30 days (41.7 ± 20.1 vs. 27.2 ± 15.9 mL, 
p = 0.029). There were no significant differences in the proportion of patients with 
respiratory distress syndrome, patent ductus arteriosus, severe intraventricular 
hemorrhage, ROP or CLD between the two groups. The laboratory data, except 
reticulocyte count, showed no significant difference on day 30. Further analysis of 
premature babies with and without CLD showed that total transfused blood volume 
greater than 30 mL over 30 days was a risk factor for developing CLD in VLBW 
infants.
Conclusion: Both criteria of PRBC transfusion had similar clinical outcomes, although 
liberal transfusion resulted in a greater amount of blood transfused and a low retic-
ulocyte count at 30 days of age. We suggest restrictive criteria for minimizing the 
overall amount of transfusion to less than 30 mL may be a better way of preventing 
CLD in VLBW infants.
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1. Introduction
Preterm infants, especially those with very low birth 
weight (VLBW) prematurity, often need multiple 
blood transfusions during hospitalization. Packed red 
blood cells (PRBC) are the most common blood com-
ponent to be administered to such neonates. Over 
50−80% of the preterm infants with body weight at 
birth of less than 1250 g receive PRBC transfusion 
at least once during their neonatal intensive care 
unit (NICU) stay.1
The major causes of anemia in these VLBW in-
fants are thought to be nutritional deficiencies, 
iatrogenic blood loss, immaturity of the hematopoi-
etic system, shorter RBC life span, and blood loss 
because of medical conditions such as sepsis, hemo-
lysis or bleeding disorders and surgery.2 Anemia may 
lead to tachycardia or bradycardia, tachypnea, in-
creased frequency of apnea and bradycardia, poor 
weight gain, poor feeding, decreased activity and 
increased oxygen requirements. Anemia can also be 
fatal. In these infants, the goal of PRBC transfusion 
is to maintain oxygen delivery without increasing 
oxygen consumption.3
The advantage of blood transfusion is the im-
provement of symptoms and signs of anemia. The 
reported outcomes of PRBC transfusion for anemia 
of prematurity include improved oxygenation, im-
proved weight gain, and decreased lactic acidosis,4 
although some reports have revealed that transfu-
sion in premature infants with lower hematocrit 
levels do not appear to alter respiratory outcomes, 
length of hospitalization or growth.5 In addition, 
Dani et al investigated the effect of blood transfu-
sions on cerebral hemodynamics in preterm infants; 
they reported that blood transfusions improve cere-
bral oxygen supply and induce a decrease in cere-
bral blood volume, probably due to an increase in 
cerebral vessel resistance.6
The complications and potential risks of PRBC 
transfusions include infection from blood contami-
nated with organisms such as cytomegalovirus, hepa-
titis B and C, and human immunodeficiency virus 
(HIV), metabolic and cardiovascular complications, 
hypothermia, graft-versus-host disease, iron overload 
and increased oxidative stress. Increased oxidative 
stress is thought to be related to complications in 
premature infants such as chronic lung disease (CLD) 
and retinopathy of prematurity (ROP).7−10 Prema-
ture infants receiving multiple PRBC transfusions 
showed evidence of iron overload, as manifested 
by the presence of free iron and saturated trans-
ferrin levels in the plasma, and histopathological 
evidence of iron overload in the liver.11,12 Free iron 
could catalyze the production of toxic reactive 
oxygen species (Fenton reaction; H2O2 + Fe2+  ·OH + 
OH− + Fe3+), resulting in free radical-induced injury 
of the immature lung and retina.13 Considering the 
available evidence, most neonatologists attempt to 
reduce the number of transfusions, although there 
is no clear guidance in deciding when premature 
infants should receive PRBC transfusions.
For each preterm infant, the benefit of RBC trans-
fusion should be weighed against the potential risks 
and complications; therefore, the decision on PRBC 
transfusion is often difficult. There is considerable 
variation in opinion and practice between clinicians 
and institutions, and evidence-based studies to guide 
clinical management are few.14,15 Bell et al con-
ducted a randomized trial of liberal versus restrictive 
guidelines for RBC transfusion in preterm infants and 
showed that restrictive transfusions may be harm-
ful to preterm infants. Infants in the restrictive 
transfusion group were more likely to have intra-
parenchymal brain hemorrhage or periventricular 
leukomalacia, and had more frequent episodes of 
apnea.16 Therefore, more evidence is necessary to 
understand the effect of transfusion to yield ap-
propriate guidance for PRBC transfusion in VLBW 
premature infants. The purpose of this study was 
to examine the outcome of VLBW premature infants 
using either restrictive or liberal criteria for PRBC 
transfusion in NICU, and the possible mechanisms 
involved were explored.
2. Subjects and Methods
2.1. Subjects
Premature infants with birth weight less than 
1500 g who were admitted to the NICU of Kaohsiung 
Medical University Hospital (KMUH) between July 
2005 and June 2006 were enrolled. Patients with 
major birth defects or chromosomal abnormality 
were excluded from this study. Informed consent 
was obtained from the parents of all patients be-
fore inclusion. We did not use the informed consent 
form of the IRB; instead, we used the blood trans-
fusion agreement of KMUH, which explained to the 
parents the benefits of blood transfusion and the 
risks of blood transfusion before enrollment.
After obtaining informed consent, the prema-
ture infants were randomly allocated to either a 
“restrictive” or a “liberal” group. The criteria of 
blood transfusion were based on respiratory status 
as follows. In the “restrictive” group, the hemat-
ocrit should be maintained at more than 35% in 
infants with assisted ventilation, more than 30% in 
infants with nasal continuous positive airway pres-
sure (CPAP) support, and more than 22% in infants 
breathing spontaneously. In the “liberal” group, the 
hematocrit should be kept at more than 45% in 
infants with assisted ventilation, more than 40% in 
112 H.L. Chen et al
infants with nasal CPAP support, and more than 30% 
in infants breathing spontaneously.16 The volume of 
each transfusion was 10 mL/kg.
2.2.  Laboratory examinations and 
medical records
Blood examinations, including complete blood count 
(CBC), reticulocyte counts, and lactate, serum iron 
and ferritin concentrations were performed at ad-
mission and 30 days later. We recorded the follow-
ing data for each patient: gestational age (GA), birth 
weight, sex, inborn or outborn, single or multiple 
birth, Apgar score, daily blood sampling amount, 
age at first transfusion, number and total volume 
of PRBC transfusions in 30 days, complications and 
outcomes such as intraventricular hemorrhage, 
apnea and bradycardia, ROP, and oxygen depend-
ence status at 28 days and at postconceptional age 
(PCA) of 36 weeks.
2.3. Statistical analysis
Descriptive results of continuous variables are ex-
pressed as means ± standard deviation. The two 
groups were compared using the Mann-Whitney 
U test (or the nonparametric Kruskal-Wallis test when 
appropriate) for numerical data and the χ2 test (or 
the Fisher exact test as appropriate) for categori-
cal data. Multiple logistic regression analysis was 
performed to investigate the association between 
total transfusion volume of PRBCs and the clinical 
outcomes in both groups. For binary analysis of total 
transfusion volume of PRBCs, we chose the median 
value of total transfusion volume (i.e. 30 mL) in our 
patients as the cutoff. We used JMP 6.0.0 desktop 
statistical discovery software from SAS to complete 
the statistical analysis.
To estimate the sample size, we computed the 
sample size needed to be able to detect a differ-
ence in the mean number of transfusions in 30 days 
between these two groups equal to one transfusion, 
with α = 0.05 and power = 0.80. This analysis pro-
duced a required sample of 17 infants per group 
with a total of 34 patients.
3. Results
Between July 2005 and June 2006, 36 VLBW prema-
ture infants were admitted to the NICU of KMUH. 
Nineteen patients were in the restrictive group and 
17 were in the liberal group. The characteristics 
including GA, birth weight, sex, inborn or outborn, 
Apgar score, and initial hemoglobin level were not 
different between these two groups (Table 1). Two 
infants in the restrictive group died during the 
study period; one had Grade 4 intraventricular he-
morrhage and the other had massive pulmonary 
hemorrhage. One infant in the liberal group died 
because of tension pneumothorax. These three cases 
were excluded from the statistical analysis.
Infants in the liberal group received a greater 
PRBC transfusion volume compared with the restric-
tive group over 30 days (41.7 ± 20.1 vs. 27.2 ± 15.9 mL, 
p = 0.029) (Table 2). However, there were no signifi-
cant differences in the percentage of infants with 
respiratory distress syndrome, patent ductus arteri-
osus, severe intraventricular hemorrhage, ROP, oxy-
gen dependence at 28 days old, oxygen dependence 
Table 1 Patient characteristics
 Restrictive transfusion Liberal transfusion 
p-value
 (n = 19) (n = 17)
Birth weight (g) 1123.7 ± 308.9 1178.2 ± 271.8 0.579
Gestational age (wk) 29.1 ± 3.0 29.1 ± 2.7 0.983
Inborn, n (%) 11 (10.5) 8 (47.1) 0.516
Male, n (%) 12 (63.2) 9 (52.9) 0.535
Multiple births, n (%) 6 (31.6) 2 (11.8) 0.153
Apgar score at 1 minute 5.1 ± 1.8 5.8 ± 1.6  0.250
Apgar score at 5 minutes 6.9 ± 1.2 7.5 ± 1.2 0.201
Initial hemoglobin (g/dL) 15.3 ± 2.0 15.0 ± 2.0 0.675
Respiratory distress syndrome, n (%) 16 (94.1) 15 (93.8) 0.965
 Grade 3 or 4, n (%) 9 (52.9) 4 (25.0) 0.101
 Exogenous surfactant use, n (%) 6 (35.3) 6 (37.5) 0.895
Death before day 30, n (%) 2 (10.5) 1 (5.9) 0.337
Continuous data are presented as means ± standard deviation.
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at PCA 36 weeks, and hospital stay between the 
two groups (Table 3). There was a greater number 
of episodes of apnea in the restrictive group than 
in the liberal group, although this was not signifi-
cantly different. The weekly weight gain and the 
time to regain birth weight (Table 3) were not sig-
nificantly different between the two groups at day 
30, nor were the laboratory data different, except 
for reticulocyte count (Table 4). The reticulocyte 
count in the restrictive group at day 30 was sig-
nificantly higher than that in the liberal group 
(3.9 ± 2.6 vs. 2.4 ± 1.3%, p = 0.041).
We next analyzed prematurity with and without 
CLD, which was defined as oxygen dependence 
at 28 days old. One case with early onset of strep-
tococcus group B (GBS) sepsis and pneumonia was 
excluded because oxygen dependence might have 
resulted from GBS infection at birth. Of the infants 
Table 2 Packed red blood cell transfusion in both groups*
 Restrictive transfusion Liberal transfusion 
p-value
 (n = 17) (n = 16)
Age at first transfusion (d) 12.5 ± 7.4  12.9 ± 9.2 0.894
Total number of transfusions per infant by day 30 2.5 ± 1.9  3.8 ± 2.5 0.130
Total blood volume removed by day 30 (mL) 56.6 ± 16.2 62.0 ± 17.3 0.363
Total blood volume transfused by 30 days old (mL) 27.2 ± 15.9 41.7 ± 20.1 0.029
Continuous data are presented as means ± standard deviation.*Patients who died during the study period were excluded from the 
analysis.
Table 3 Clinical outcomes*
 Restrictive transfusion Liberal transfusion 
p-value
 (n = 17) (n = 16)
Patent ductus arteriosus, n (%) 9 (52.9) 12 (75) 0.188
Intraventricular hemorrhage
 Any grade, 1−4, n (%) 5 (29.4) 4 (25.0) 0.776
 Grade 3 or 4, n (%) 1 (5.9) 2 (12.5) 0.509
Retinopathy of prematurity
 Total, n (%) 4 (23.5) 4 (25.0) 0.922
 ≥ Stage 3, n (%) 0 (0) 2 (12.5) 0.133
Oxygen dependence at 28 days of age, n (%) 9 (52.9) 5 (31.3) 0.208
Oxygen dependence at PCA 36 weeks, n (%) 5 (29.4) 3 (18.8) 0.475
Sepsis during the study period, n (%) 9 (52.9) 11 (68.8) 0.353
Time on ventilator or CPAP (d) (median) 34.9 ± 26.9 (34) 22.7 ± 29.4 (13)  0.237
Apnea of prematurity, n (%) 12 (70.6) 10 (62.5) 0.622
Number of episodes of apnea† during the 18.5 ± 25.3 (18) 11.9 ± 20.3 (4) 0.442
 study period (median)
Necrotizing enterocolitis, n (%) 1 (5.9) 0 (0) 0.325
Weight gain (g)
 Weight gain during Week 1 −200.9 ± 88.5 −172.3 ± 120.1 0.510
 Weight gain during Week 2 65.5 ± 69.6 68.5 ± 75.7 0.920
 Weight gain during Week 3 119.1 ± 91.6 113.8 ± 90.0 0.889
 Weight gain during Week 4 108.2 ± 77.3 113.9 ± 58.7 0.844
 Weight gain during Week 5 135.5 ± 72.3 93.3 ± 101.7 0.263
Time to regain birth weight (d) 17.8 ± 7.2 23.9 ± 14.3 0.159
Time to double birth weight (d) 67.8 ± 16.7 73.1 ± 18.6 0.529
Hospital stay (d) 74.9 ± 28.2 77.6 ± 45.0 0.852
Continuous data are presented as means ± standard deviation. *Patients who died during the study period were excluded from 
the analysis. †Apnea episodes included apnea with and without bradycardia. CPAP = continuous positive airway pressure; 
PCA = postconceptional age.
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with prematurity with CLD (n = 13), four were in 
the liberal transfusion group and nine were in the 
restrictive transfusion group. Compared with the 
infants with prematurity without CLD (n = 19; 11 
patients in the liberal transfusion group), there 
was no statistical difference in the proportion of 
cases with liberal transfusion between these groups 
(p = 0.131; χ2 test). Analysis of prematurity with 
and without CLD revealed that the GA and birth 
weight were significantly lower in cases with CLD 
than those without CLD (GA: 28.1 ± 2.2 vs. 30.5 ± 2.4 
weeks, p = 0.009; birth weight: 1039.2 ± 271.8 vs. 
1318.9 ± 183.9 g, p = 0.001). The cases with CLD also 
had worse Apgar score at 5 minutes (7.0 ± 1.2 vs. 
7.7 ± 0.8, p = 0.048), greater total number of trans-
fusions (4.2 ± 2.0 vs. 2.0 ± 1.4, p = 0.001) and greater 
overall volume of blood transfused over 30 days 
(41.6 ± 13.3 vs. 26.4 ± 16.6 mL, p = 0.010). In consid-
eration of the interactions among GA, birth weight, 
Apgar score at 5 minutes and blood volume trans-
fused during 30 days, we entered these variables 
into a multiple logistic regression analysis to de-
termine the effect of transfused blood volume on 
development of CLD. After controlling for these 
variables, the risk of developing CLD was 29 times 
higher in VLBW infants who were transfused with 
more than 30 mL of PBRCs over 30 days (adjusted 
odds ratio [OR]: 29.13, 95% confidence interval [CI]: 
2.167−391.407; p = 0.011) (Table 5).
4. Discussion
Over 50−80% of preterm infants with birth weight 
less than 1250 g receive at least one PRBC transfu-
sion during their stay in the NICU.1 With premature 
infants being one of the most commonly transfused 
patient populations, concerns over blood transfu-
sions in these patients have been discussed for many 
years. However, very few clinical trials have pro-
vided clear guidance in deciding when small prema-
ture infants should receive PRBC transfusion. In 
terms of the clinical considerations, the reasons 
for transfusing these tiny babies are generally not 
to replace iatrogenic losses only,2 but are instead 
based on correcting a low hematocrit and clinical 
symptoms and signs. Transfusions to VLBW prema-
ture infants could increase weight gain, improve 
oxygenation and decrease lactic acidosis.4 Stute 
et al revealed that transfusion improved cardio-
pulmonary function in preterm infants for several 
days.17 However, other authors have reported that 
Table 4 Physiology measurements before transfusion day 30
 Restrictive transfusion Liberal transfusion 
p-value
 (n = 17) (n = 16)
Hemoglobin (g/dL) 10.4 ± 2.1 10.3 ± 1.7 0.849
Hematocrit (%) 29.9 ± 6.0 29.8 ± 5.1 0.965
Reticulocyte count (%) 3.9 ± 2.6 2.4 ± 1.3 0.041
Blood lactate (mEq/L) 1.6 ± 0.7 1.5 ± 0.6 0.656
Serum ferritin (μg/L) 217.3 ± 175.6 293.5 ± 257.1 0.340
Serum iron (μg/d) 62.3 ± 23.4 69.8 ± 18 0.322
Transferrin saturation (%) 38.9 ± 16.2 43.5 ± 15.2 0.428
Continuous data are presented as means ± standard deviation.
Table 5 Risk factors associated with oxygen dependence in very low body weight premature infants at 28 days old
Variable
 No oxygen use Oxygen dependence Adjusted ORs* 
p-value
 at day 28 (n = 19) at day 28 (n = 13) (95% CI)
Total volume of PRBC transfusion
 in 30 days, n (%)
 > 30 mL 5 (26.3%) 11 (84.6%) 29.13 (2.167−391.407) 0.011
 ≤ 29 mL 14 (73.7%) 2 (15.4%) 1
GA†, mean ± SD 30.5 ± 2.4 28.1 ± 2.2 0.595 (0.294−1.204) 0.149
Birth weight†, mean ± SD  1318.9 ± 183.9 1039.2 ± 271.8 0.998 (0.991−1.004) 0.495
Apgar score at 5 minutes†, mean ± SD 7.7 ± 0.8 7.0 ± 1.2 0.743 (0.199−2.774) 0.658
*Adjusted ORs were estimated by multiple logistic regression after adjusting for GA, birth weight and Apgar score at 5 minutes. 
†GA, birth weight, and Apgar score at 5 minutes were analyzed as continuous variables. CI = confidence interval; GA = gestational 
age; OR = odds ratio; PRBC = packed red blood cells; SD = standard deviation.
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transfusion to infants with low hematocrit did not 
alter respiratory outcomes, length of hospitalization 
or growth.5,18,19
The complications and potential risks of PRBC 
transfusions include blood-transmitted infection, 
metabolic and cardiovascular complications, graft-
versus-host disease, iron overload, and increased 
oxidative stress, which are thought to be related 
to complications in premature infants such as CLD 
and ROP.7−10 Considering the above complications 
and risks, in recent years, most institutions have 
implemented more restrictive transfusion guidelines 
to reduce the frequency of transfusions and donor 
exposures.4,20−22 However, there is little informa-
tion on the safety of transfusions or the lowest tol-
erable hemoglobin levels. In this study, we did not 
observe any complications or risks in the restric-
tive group. Nevertheless, Bell et al showed more 
frequent major adverse neurologic events in the 
restrictive-transfusion group, and they suggested 
that restrictive transfusions may be harmful to pre-
mature infants.16 Their study was not conclusive, 
and there have been several discussions after its 
publication.23−26
The common pathogenic factors that contribute 
to CLD include incomplete lung development, 
mechanical trauma, oxidative injury, perinatal and 
nosocomial infections, patent ductus arteriosus and 
pulmonary edema.27 CLD in premature infants is 
thought to be related, at least in part, to oxidant 
injury of the immature lung. The sources of oxi-
dant injury include oxygen-derived free radicals and 
free iron that catalyze the production of toxic reac-
tive oxygen species via the Fenton reaction.13 PRBC 
transfusion might increase oxidative stress. In our 
study, multiple regression analysis revealed that the 
risk factor associated with development of CLD in 
VLBW infants was an overall volume of transfused 
blood of more than 30 mL in 30 days (adjusted OR 
29.13, 95% C.I. 2.167−391.407, p = 0.011). Cooke 
et al showed that premature infants with CLD re-
ceived more blood transfusion than those infants 
without CLD after standardization of GA, birth 
weight, and days of ventilation in a logistic regres-
sion analysis.7 However, they did not record the 
total volume of blood transfused. Our present 
study might have some limitations. There might be 
other factors besides the greater amount of blood 
transfusion that might also contribute to the for-
mation of CLD, and those factors were not included 
in the logistic regression.
In conclusion, we showed that both criteria for 
PRBC transfusion had similar clinical outcomes, al-
though liberal transfusion resulted in a greater 
amount of blood transfused and lower reticulocyte 
count at day 30. Restrictive criteria to minimize the 
total amount of transfusion to less than 30 mL may 
be beneficial in preventing CLD in VLBW infants. 
Our results provide further information to guide the 
clinical decision for appropriate PRBC transfusion.
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